Cancer Incidence and Mortality Worldwide: IARC CancerBase [Internet]: International Agency for Research on Cancer ,
National Cancer Institute; 2013 Available from: http://seer.cancer, Cancer Statistics Review, 1975. ,
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial, The Lancet Oncology, vol.14, issue.8, pp.760-768, 2013. ,
DOI : 10.1016/S1470-2045(13)70184-0
Evaluation of Prostate-Specific Antigen Declines for Surrogacy in Patients Treated on SWOG 99-16, JNCI Journal of the National Cancer Institute, vol.98, issue.8, pp.516-537, 2006. ,
DOI : 10.1093/jnci/djj129
Determinants of Change in Prostate-Specific Antigen Over Time and Its Association With Recurrence After External Beam Radiation Therapy for Prostate Cancer in Five Large Cohorts, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.3, pp.782-91, 2008. ,
DOI : 10.1016/j.ijrobp.2008.01.056
URL : https://hal.archives-ouvertes.fr/inserm-00263863
A Two-Stage Joint Model for Nonlinear Longitudinal Response and a Time-to-Event with Application in Transplantation Studies, Journal of Probability and Statistics, vol.15, issue.3957 ,
DOI : 10.1002/sim.3153
Available from: http://www.hindawi.com/journals/jps, p.2012, 2012. ,
Analysis of Longitudinal and Survival Data: Joint Modeling, Inference Methods, and Issues, Journal of Probability and Statistics, vol.57, issue.1, 2011. ,
DOI : 10.1214/009053605000000480
Joint modelling of longitudinal and time-to-event data with application to predicting abdominal aortic aneurysm growth and rupture, Biometrical Journal, vol.27, issue.5, pp.750-63, 2011. ,
DOI : 10.1002/bimj.201100052
Basic Concepts and Methods for Joint Models of Longitudinal and Survival Data, Journal of Clinical Oncology, vol.28, issue.16, pp.2796-801, 2010. ,
DOI : 10.1200/JCO.2009.25.0654
Surrogate markers and joint models for longitudinal and survival data, Controlled Clinical Trials, vol.23, issue.6, pp.626-660, 2002. ,
DOI : 10.1016/S0197-2456(02)00234-9
A Joint Model for Survival and Longitudinal Data Measured with Error, Biometrics, vol.53, issue.1, p.330, 1997. ,
DOI : 10.2307/2533118
Joint modeling of longitudinal and time-to-event data: an overview, Stat. Sin, vol.14, pp.809-843, 2004. ,
Joint Modeling of Survival and Longitudinal Data: Likelihood Approach Revisited, Biometrics, vol.14, issue.4, pp.1037-1080, 2006. ,
DOI : 10.1111/j.1541-0420.2006.00570.x
Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.6, pp.387-404, 2003. ,
DOI : 10.1023/B:JOPA.0000012998.04442.1f
Joint modelling of longitudinal measurements and event time data, Biostatistics, vol.1, issue.4, pp.465-80, 2000. ,
DOI : 10.1093/biostatistics/1.4.465
Joint Models for Longitudinal and Time-to-Event Data: With Applications in R, 2012. ,
DOI : 10.1201/b12208
A Joint Model for Nonlinear Longitudinal Data with Informative Dropout, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.1, pp.83-103, 2003. ,
DOI : 10.1023/A:1023249510224
Performance of Nonlinear Mixed Effects Models in the Presence of Informative Dropout, The AAPS Journal, vol.17, issue.1, pp.245-55, 2014. ,
DOI : 10.1208/s12248-014-9700-x
Evaluation of Estimation Methods and Power of Tests of Discrete Covariates in Repeated Time-to-Event Parametric Models: Application to Gaucher Patients Treated by Imiglucerase, The AAPS Journal, vol.16, issue.3, pp.415-438, 2014. ,
DOI : 10.1208/s12248-014-9575-x
URL : https://hal.archives-ouvertes.fr/inserm-00967034
Joint modelling of longitudinal and repeated time-to-event data using nonlinear mixed-effects models and the stochastic approximation expectation???maximization algorithm, Journal of Statistical Computation and Simulation, vol.30, issue.8, pp.1512-1540, 2015. ,
DOI : 10.1007/s10928-012-9248-2
Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF-??1 and bcl-2 expression, International Journal of Cancer, vol.69, issue.5, pp.357-63, 1996. ,
DOI : 10.1002/(SICI)1097-0215(19961021)69:5<357::AID-IJC1>3.0.CO;2-4
PROSTATE SPECIFIC ANTIGEN, The Journal of Urology, vol.162, pp.293-306, 1999. ,
DOI : 10.1097/00005392-199908000-00003
Fully exponential Laplace approximations for the joint modelling of survival and longitudinal data, Journal of the Royal Statistical Society: Series B (Statistical Methodology), vol.11, issue.3, pp.637-54, 2009. ,
DOI : 10.1111/j.1467-9868.2008.00704.x
R: A language and environment for statistical computing. R Foundation for Statistical Computing, www.R-project.org. R Foundation for Statistical Computing, 2013. ,
Individualized Predictions of Disease Progression Following Radiation Therapy for Prostate Cancer, Journal of Clinical Oncology, vol.23, issue.4, pp.816-841, 2005. ,
DOI : 10.1200/JCO.2005.12.156
The Use of Model-Based Tumor-Size Metrics to Predict Survival, Clinical Pharmacology & Therapeutics, vol.2, issue.2, pp.133-138, 2014. ,
DOI : 10.1038/clpt.2014.111
URL : https://hal.archives-ouvertes.fr/inserm-01084276
Joint longitudinal survival cure models and their application to prostate cancer, Stat. Sin, vol.14, pp.835-62, 2004. ,
A Review of Mixed-Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis, CPT Pharmacometrics Syst. Pharmacol., vol.59, issue.5, p.113, 2014. ,
DOI : 10.1016/j.jtbi.2012.12.013